IN2014MU00072A - - Google Patents

Info

Publication number
IN2014MU00072A
IN2014MU00072A IN72MU2014A IN2014MU00072A IN 2014MU00072 A IN2014MU00072 A IN 2014MU00072A IN 72MU2014 A IN72MU2014 A IN 72MU2014A IN 2014MU00072 A IN2014MU00072 A IN 2014MU00072A
Authority
IN
India
Prior art keywords
rivaroxaban
preparation
pharmaceutically acceptable
acceptable salt
present
Prior art date
Application number
Other languages
English (en)
Inventor
Jagdish Dattopant Shukla
Ramprasad Yadav
Arvind Yekanathsa Merwade
Keshav Deo
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN72MU2014 priority Critical patent/IN2014MU00072A/en
Priority to PCT/IB2014/067072 priority patent/WO2015104605A1/en
Publication of IN2014MU00072A publication Critical patent/IN2014MU00072A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
IN72MU2014 2014-01-08 2014-12-18 IN2014MU00072A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN72MU2014 IN2014MU00072A (zh) 2014-01-08 2014-12-18
PCT/IB2014/067072 WO2015104605A1 (en) 2014-01-08 2014-12-18 A process for preparing rivaroxaban or a pharmaceutically acceptable salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN72MU2014 IN2014MU00072A (zh) 2014-01-08 2014-12-18

Publications (1)

Publication Number Publication Date
IN2014MU00072A true IN2014MU00072A (zh) 2015-08-21

Family

ID=53523577

Family Applications (1)

Application Number Title Priority Date Filing Date
IN72MU2014 IN2014MU00072A (zh) 2014-01-08 2014-12-18

Country Status (2)

Country Link
IN (1) IN2014MU00072A (zh)
WO (1) WO2015104605A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210163423A1 (en) * 2015-02-17 2021-06-03 Neupharma, Inc. Certain chemical entities, compositions, and methods

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3740716B2 (ja) * 1994-08-04 2006-02-01 和光純薬工業株式会社 アシルチオコリン誘導体およびその用途
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE102004002044A1 (de) 2004-01-15 2005-08-04 Bayer Healthcare Ag Herstellverfahren
JP2006056812A (ja) * 2004-08-19 2006-03-02 Ube Ind Ltd ６，６−ジフルオロ−５−ヘキセン−１−チオール誘導体及び農園芸用の有害生物防除剤
DE102006048042A1 (de) * 2006-10-11 2008-04-17 Bayer Healthcare Ag Acylaminoimidazole und Acylaminothiazole
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
SI2459555T1 (sl) 2009-07-31 2022-03-31 Krka, D.D., Novo Mesto Postopek kristalizacije rivaroksabana
EP2521723A1 (en) 2010-01-04 2012-11-14 Enantia, S.L. Process for the preparation of rivaroxaban and intermediates thereof
EP2354128A1 (en) 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
JP6325978B2 (ja) 2011-05-06 2018-05-16 エギシュ ヂョヂセルヂャール ザートケルエン ミケデ レースヴェーニタールササーグ リバロキサバンの製法及び該方法において形成される中間体
WO2012156983A1 (en) 2011-05-16 2012-11-22 Symed Labs Limited Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
EP2753619A2 (en) 2011-09-08 2014-07-16 Cadila Healthcare Limited Processes and intermediates for preparing rivaroxaban
WO2013053739A1 (en) 2011-10-10 2013-04-18 Laboratorios Lesvi, S. L. Process for preparing factor xa inhibitors
CZ2012114A3 (cs) 2012-02-17 2013-02-20 Zentiva, K.S. Zpusob prípravy rivaroxabanu zalozený na úspore 1,1´ -karbonyldiimidazolu
US9562040B2 (en) 2012-04-06 2017-02-07 Indiana University Research And Technology Corporation Processes for preparing Rivaroxaban
US20150299160A1 (en) 2012-04-16 2015-10-22 Ranbaxy Laboratories Limited Process for the preparation of rivaroxaban and intermediates thereof
CN104487436B (zh) 2012-05-02 2017-05-24 信谊实验室有限公司 使用中间产物制备利伐沙班的改良方法
CN104098556B (zh) * 2013-04-09 2019-01-08 浙江九洲药物科技有限公司 一种利伐沙班的合成工艺

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210163423A1 (en) * 2015-02-17 2021-06-03 Neupharma, Inc. Certain chemical entities, compositions, and methods

Also Published As

Publication number Publication date
WO2015104605A1 (en) 2015-07-16

Similar Documents

Publication Publication Date Title
MX2017006266A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos.
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
GR20140100479A (el) Συνθεση λιραγλουτιδης
IN2014CH00247A (zh)
MX2016016297A (es) Procedimientos para la preparacion de compuestos antivirales.
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
MX2020003020A (es) Compuestos de aminocarbonilcarbamato.
PH12016501613B1 (en) Pyrazines modulators of gpr6
PH12017501404A1 (en) Diaza-benzofluoranthrene compounds
MX2019001228A (es) Metodo de produccion del compuesto de pirazol-amida.
IN2014MU01192A (zh)
IN2014MU00195A (zh)
MX2016015465A (es) Composicion farmaceutica oral de isotretinoina.
MX2016015298A (es) Inhibidores de nampt y metodos.
IN2014MU00072A (zh)
IN2014MU00194A (zh)
IN2014MU01196A (zh)
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2017004770A (es) Formas solidas del clorhidrato de nilotinib.
IN2013MU03670A (zh)
IN2014MU00070A (zh)
IN2014MU00566A (zh)
IN2014MU00858A (zh)